Android Apple

Analysts Expect Breakeven For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Before Long

By Yahoo! Finance   |   5 months ago
Analysts Expect Breakeven For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Before Long

Intra-Cellular Therapies, Inc., a biopharmaceutical company, is approaching breakeven with analysts predicting profitability in 2025 after a loss of US$140m in the previous year. The company's debt-free status reduces investment risk.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.